tiprankstipranks
BioLineRX Ltd. (IL:BLRX)
TASE:BLRX
Israel Market
BLRX
Bioline Rx
RESEARCH TOOLSreports
Want to see IL:BLRX full AI Analyst Report?

Bioline Rx (BLRX) Income Statement

2 Followers

Bioline Rx Income Statement

Last quarter (Q4 2025), Bioline Rx's total revenue was $198.00K, a decrease of -22.35% from the same quarter last year. In Q4, Bioline Rx's net income was $-1.41M. See Bioline Rx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 1.28M$ 28.94M$ 4.80M$ 0.00$ 0.00
Gross Profit
$ 462.21K$ 19.68M$ 1.11M$ 0.00$ 0.00
Operating Expenses
$ 11.60M$ 40.09M$ 50.80M$ 29.16M$ 24.78M
Depreciation and Amortization
$ 566.13K$ 4.07M$ 1.38M$ 654.00K$ 703.00K
EBITDA
$ -10.57M$ 3.92M$ -57.09M$ -28.50M$ -24.07M
Operating Income
$ -11.14M$ -20.41M$ -49.69M$ -29.16M$ -24.78M
Other Income/Expenses
$ 8.94M$ 11.19M$ -10.92M$ 4.21M$ -2.28M
Pretax Income
$ -2.19M$ -9.22M$ -60.61M$ -24.95M$ -27.05M
Net Income
$ -1.27M$ -9.22M$ -60.61M$ -20.75M$ -28.14M
Per Share Metrics
Basic EPS
$ >-0.01$ -0.01$ -0.06$ -0.03$ -0.04
Diluted EPS
$ >-0.01$ -0.01$ -0.06$ -0.03$ -0.04
Weighted Average Shares Outstanding
 2.47B 1.20B 963.37M 773.96M 662.93M
Weighted Average Shares Outstanding (Diluted)
 2.47B 1.20B 963.37M 773.96M 662.93M
Currency in USD

Bioline Rx Earnings and Revenue History